BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12706932)

  • 1. Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women.
    Vongpatanasin W; Tuncel M; Wang Z; Arbique D; Mehrad B; Jialal I
    J Am Coll Cardiol; 2003 Apr; 41(8):1358-63. PubMed ID: 12706932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ; Ho KK; Lazarus L
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women.
    Shifren JL; Rifai N; Desindes S; McIlwain M; Doros G; Mazer NA
    J Clin Endocrinol Metab; 2008 May; 93(5):1702-10. PubMed ID: 18303079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women.
    Abbas A; Fadel PJ; Wang Z; Arbique D; Jialal I; Vongpatanasin W
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):e164-7. PubMed ID: 15284085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration route-dependent effects of estrogens on IGF-I levels during fixed GH replacement in women with hypopituitarism.
    van der Klaauw AA; Biermasz NR; Zelissen PM; Pereira AM; Lentjes EG; Smit JW; van Thiel SW; Romijn JA; Roelfsema F
    Eur J Endocrinol; 2007 Dec; 157(6):709-16. PubMed ID: 18057377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
    Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P
    Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women.
    Rachoń D; Suchecka-Rachoń K; Hak Ł; Myśliwska J
    Menopause; 2006; 13(5):840-5. PubMed ID: 16894332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of atherosclerosis in postmenopausal women: alteration of atherosclerosis-associated factors and vascular atherosclerosis by oral and transdermal estrogen replacement].
    Sumino H; Murakami M
    Rinsho Byori; 2013 Mar; 61(3):256-62. PubMed ID: 23785796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women.
    Decensi A; Omodei U; Robertson C; Bonanni B; Guerrieri-Gonzaga A; Ramazzotto F; Johansson H; Mora S; Sandri MT; Cazzaniga M; Franchi M; Pecorelli S
    Circulation; 2002 Sep; 106(10):1224-8. PubMed ID: 12208797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.
    O'Sullivan AJ; Crampton LJ; Freund J; Ho KK
    J Clin Invest; 1998 Sep; 102(5):1035-40. PubMed ID: 9727072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women.
    Vongpatanasin W; Tuncel M; Mansour Y; Arbique D; Victor RG
    Circulation; 2001 Jun; 103(24):2903-8. PubMed ID: 11413078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral and transdermal estrogen therapies on circulating cytokines and chemokines in postmenopausal women with hysterectomy.
    Yasui T; Saijo A; Uemura H; Matsuzaki T; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
    Eur J Endocrinol; 2009 Aug; 161(2):267-73. PubMed ID: 19451213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of dose and route of estrogen administration on the somatotropic axis in normal women.
    Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4668-72. PubMed ID: 14557438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
    Slowinska-Srzednicka J; Zgliczynski S; Jeske W; Stopinska-Gluszak U; Srzednicki M; Brzezinska A; Zgliczynski W; Sadowski Z
    J Endocrinol Invest; 1992; 15(7):533-8. PubMed ID: 1280287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
    O'Sullivan AJ; Ho KK
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transdermal estrogen replacement therapy on cardiovascular risk factors.
    Menon DV; Vongpatanasin W
    Treat Endocrinol; 2006; 5(1):37-51. PubMed ID: 16396517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.
    Sonnet E; Lacut K; Roudaut N; Mottier D; Kerlan V; Oger E
    Clin Endocrinol (Oxf); 2007 May; 66(5):626-31. PubMed ID: 17492948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
    Lakoski SG; Herrington DM
    Climacteric; 2005 Dec; 8(4):317-26. PubMed ID: 16390766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.